期刊文献+

热疗加阿霉素对慢性白血病K562细胞株的抑制作用 被引量:1

Suppression effect of adriamycin combined with hypertherma on chronic leukemic K562 cell line
下载PDF
导出
摘要 目的观察热疗联合阿霉素对慢性髓系白血病细胞株K562的体外增殖抑制作用及凋亡的影响。方法采用MTT法确定阿霉素的工作浓度,以该浓度进行化疗或与热疗的联合,选择温度40℃及42℃,体外作用于K562。作用前及48h,采用台盼蓝拒染法检测肿瘤细胞的存活率;MTT法检测对肿瘤细胞增殖的抑制作用;流式细胞仪检测细胞凋亡。观察热疗联合阿霉素的抗肿瘤效果。结果作用48h后IC50为5μg/ml,以此为实验的工作浓度。单纯热疗60min对K562细胞有抑制作用(P<0.01),并随温度增高而增强;单纯化疗对K562细胞也有抑制作用;各热化疗组对K562均有明显的抑制作用(P<0.01),随着温度的增高而增强。流式细胞仪检测细胞凋亡,热疗组、化疗组及热化疗组的细胞凋亡率均较对照组显著升高,各组之间有显著性差异(P<0.01)。结论热疗联合阿霉素能增强对K562细胞的体外抑制作用,可以提高肿瘤细胞的凋亡率。 Objective To investigate the suppression effect of adriamycin combined with hyperthermia on chronic leukemic K562 cell line.Methods The working concentration of adriamycin against K562 was determined by MTF assay.Then hyperthermia and chemotherapy were used singly or concurrently and the cell survival rates were calculated at 48h.The suppression effect was evaluated by MTT assay.The apoptosis rates of K562 were determined by flow cytometric analyses.Results The concentration of adriamycin in the experiment was defined as its ICS0.The 40℃ and 42℃ hyperthermia used for 60 rain showed obvious inhibition to K562 (P〈0.01), adriamycin chemotherapy or hyperthermia both obviously inhibited the growth of K562 (P〈0.01).Adriamycin chemotherapy combined with hyperthermia showed obvious effect to K562.According to flow cytometric analyses,hyperthermia and adriamycin used alone or concurrently all could obviously increase the apoptosis rates of K562 (P〈0.01).Conclusion Adriamycin chemotherapy combined with hyperthermia used for 60min canobviously increase suppression effect to K562. The synergism might increase apoptosis rates of K562.
出处 《实用医药杂志》 2007年第4期470-472,共3页 Practical Journal of Medicine & Pharmacy
关键词 阿霉素 热疗 K562细胞株 抑制作用 凋亡 Adriamycin Hyperthermia K562 cell line Suppression effect Apoptosis
  • 相关文献

参考文献11

二级参考文献33

  • 1贾筱琴,王正兵,陈兵,李厚达.重组TRAIL抑制7402肝癌细胞生长的实验研究[J].实用临床医药杂志,2004,8(6):22-24. 被引量:5
  • 2彭楠 赵彼得.临床肿瘤热疔[M].北京:人民军医出版社,2002.1-95.
  • 3Yeh Y A, Herenyiova M, Weber G. Quercetin: synergistic action with carboxyamidotriazole in human breast carcinoma cells[J]. Life Sci, 1995, 57(13): 1285.
  • 4Nishida Y, Hamaji M, Miyazaki S, et al. Thermo-chemotherapy using low-dose CPT-11 in a patient with local recurrence of rectal cancer[J]. Gan To Kagaku Ryoho, 1999, 26(4): 549.
  • 5Wehner H, Kaltofen S. Whole-body hyperthermia with water-filered infra-red radiation: thchnical-physical aspects and clinical experiences. Int J Hyperthermia,2001, 17:19-30.
  • 6Yatvin MB, Dennis WH, Elegbede JA, et al. Sensitivity of tumor cells to heat and ways of modifying the response. Symp Soc Exp Biol, 1987, 41: 235-267
  • 7Steeves RA. Hyperthermia in cancer therapy: Where are we today and where are we going? Bull NY Acad, 1992, 68: 342-350
  • 8Engin K. Biological rationale for hypermthermia in cancer treatment (II). Neoplasma, 1994, 41(5): 277-283
  • 9Ohnishi K, Ohnishi T. Heat-induced p53-dependent signal transduction and its role in hyperhermic cancer therapy. Int J Hyperthermia, 2001, 17(5): 415-427
  • 10Rampino N, Yamamoto H, Tonov Y, et al. Somatic frameshift mutations in the bax gene in colon cancers of the microsatellite mutator phenotype. Science, 1997, 275: 967-969

共引文献51

同被引文献18

  • 1丁向东,赵鑫,刘萍.全身热疗治疗慢性粒细胞白血病-急粒变1例[J].临床血液学杂志,2005,18(4):242-243. 被引量:9
  • 2魏红梅,郭坤元,尚振川,梅家转,常红.全身热疗系统治疗恶性血液病15例:加温、测温和控温技术的安全、顺应及有效性观察[J].中国临床康复,2006,10(8):38-40. 被引量:17
  • 3王昕,史斌,王申五,董建强,崔建英,韩淑霞.热应激对慢性粒细胞白血病细胞系K562中热休克蛋白gp96表达的影响及其意义[J].中国实验血液学杂志,2006,14(4):667-672. 被引量:2
  • 4YOSHIDA C,MELO J.Biology of chronic myeloid leukemia and possible therapeutic approaches to imatinib-resistant disease[J].Int J Haematol,2004,79(5):420-433.
  • 5JONES C,LUTHRA R,CORTES J,et al.BCR-ABL fusion transcript types and levels and their interaction with secondary genetic changes in determining the phenotype of Philadelphia chromosome0positive leukemias[J].Blood,2008,112(13):5190-5192.
  • 6SAVAGE DG,ANTMAN KH.Imatinib mesylate-a new oral targeted therapy[J].N Engl J Med,2002,346(9):683-693.
  • 7JRAS M,JOHNELS P,AGERSTAM H,et al.Expression of P190 and P210 BCR/ABL1 in normal human CD34(+) cells induces similar gene expression profiles and results in a STAT5-dependent expansion of the erythroid lineage[J].Exp Hematol.2009,37(3):367-375.
  • 8ANDREU EJ,LLEDO E,POCH E,et al.BCR-ABL induces the expression of Skp2 through the PI3K pathway to promote p27Kip1 degradation and proliferation of chronic myelogenous leukemia cells[J].Cancer Res,2005,65(8):3264-3272.
  • 9NOTARI M,NEVIANI P,SANTHANAM R,et al.A MAPK/HNRPK pathway controls BCR/ABL oncogenic potential by regulating MYC mRNA translation[J].Blood,2006,107(6):2507-2516.
  • 10ADAMS JM,CORY S.The Bcl-2 apoptotic switch in cancer development and therapy[J].Oncogene,2007,26(9):1324-1337.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部